|
?:authorAffiliation
|
-
[\'Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.\', \'Laboratory of Retrovirology, The Rockefeller University, New York, NY, USA.\', \'Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.\', \'Lymphocyte Nuclear Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.\', \'Hospital Program Direction, The Rockefeller University, New York, NY, USA.\', \'Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD, USA.\', \'Pediatric Translational Research Branch and Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.\', \'Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA. bjorkman@caltech.edu.\', \'Lymphocyte Nuclear Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA. rafael.casellas@nih.gov.\', \'The NIH Regulome Project, National Institutes of Health, Bethesda, MD, USA. rafael.casellas@nih.gov.\', \'Laboratory of Retrovirology, The Rockefeller University, New York, NY, USA. thatziio@rockefeller.edu.\', \'Laboratory of Retrovirology, The Rockefeller University, New York, NY, USA. pbieniasz@rockefeller.edu.\', \'Howard Hughes Medical Institute, The Rockefeller University, New York, NY, USA. pbieniasz@rockefeller.edu.\', \'Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA. nussen@rockefeller.edu.\', \'Howard Hughes Medical Institute, The Rockefeller University, New York, NY, USA. nussen@rockefeller.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}